A detailed history of High Vista Strategies LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 130,966 shares of TERN stock, worth $767,460. This represents 0.43% of its overall portfolio holdings.

Number of Shares
130,966
Previous 148,200 11.63%
Holding current value
$767,460
Previous $1.01 Million 8.23%
% of portfolio
0.43%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.49 - $10.8 $111,848 - $186,127
-17,234 Reduced 11.63%
130,966 $1.09 Million
Q3 2023

Nov 14, 2023

SELL
$4.7 - $8.55 $147,909 - $269,068
-31,470 Reduced 17.52%
148,200 $745,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.29 $241,197 - $436,124
32,816 Added 22.35%
179,670 $1.57 Million
Q1 2023

May 15, 2023

BUY
$7.91 - $12.0 $549,824 - $834,120
69,510 Added 89.87%
146,854 $1.74 Million
Q3 2022

Nov 14, 2022

BUY
$1.87 - $6.42 $144,633 - $496,548
77,344 New
77,344 $456,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.